QPharma has nominated Badal Shah, B.Pharm, M.S. MBA, the company’s Managing Director, KOL (Key Opinion Leader) and Targeting, to the Forbes “30 Under 30” list for Healthcare.

Shah established and leads QPharma’s thought leader engagement practice, and his approach to achieving effective medical communication and optimizing the pharma field sales force has been well received by the industry. As Managing Director, he has responsibilities for growth and business development in QPharma’s KOL engagement and healthcare practitioner (HCP) targeting business. He will also lead efforts to establish and grow the practices in Europe, Asia, and Latin America as QPharma announces new presences there.

A pharmacist and Rutgers University science and business graduate, with a specialization in Drug Discovery and Development, Shah is a member of the Advisory Board of Directors for the American Pharmacy Purchasing Alliance. He is based at QPharma’s Morristown, New Jersey headquarters.

We wish Badal continued success and good luck in the pursuit of recognition on the Forbes “30 under 30” list for Healthcare.

About QPharma, Inc.
Founded in 1994, QPharma provides a suite of solutions to the life sciences industry. The Commercial Services division provides solutions that include sample management and distribution, product launch management, online training, and HCP/KOL targeting and engagement. Services offered by the company’s Professional Services division include validation services, project management, auditing, and training. QPharma is a National Association of Boards of Pharmacy Verified Accredited Wholesale Distributor, and an approved American Medical Association Database Licensee.